Canopy Growth (CGC) Free Cash Flow (2019 - 2026)
Canopy Growth (CGC) posted Free Cash Flow of -$35.8 million for Q4 2025, down 325.71% sequentially from -$8.4 million in Q2 2025, and down 77.32% YoY from -$157.7 million in Q4 2024.
Canopy Growth (CGC) Free Cash Flow (2019 - 2026) Analysis & Trends
Canopy Growth has reported Free Cash Flow for 7 years, with the latest figure at -$35.8 million in Q4 2025.
- Quarterly Free Cash Flow fell 77.32% year-over-year to -$35.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$44.2 million (up 56.81% YoY) and the FY2026 annual result came in at -$50.4 million, up 59.03% from the prior year.
- Free Cash Flow eased to -$35.8 million in Q4 2025 per CGC's latest filing, from -$8.4 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $15.1 million in Q1 2023 and troughed at -$180.2 million in Q1 2021.
- A 5-year average of -$68.5 million and a median of -$52.6 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2023: Free Cash Flow slumped 450.2% in 2021, then soared 170.38% in 2023.
- Over 5 years, Free Cash Flow stood at -$133.6 million in 2021, then slipped by 9.19% to -$145.8 million in 2022, then jumped by 83.31% to -$24.3 million in 2023, then increased by 17.11% to -$20.2 million in 2024, then tumbled by 77.32% to -$35.8 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$35.8 million, -$8.4 million, and -$20.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | -18.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.61 Mn |
| Jun 30, 2026 | -18.61 Mn |
| Dec 31, 2025 | -35.77 Mn |
| Dec 31, 2025 | -35.77 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Dec 31, 2024 | -20.17 Mn |
| Dec 31, 2024 | -20.17 Mn |
| Sep 30, 2024 | -41.37 Mn |
| Sep 30, 2024 | -41.37 Mn |
| Jun 30, 2024 | -40.72 Mn |
| Jun 30, 2024 | -40.72 Mn |
| Mar 31, 2024 | -16.56 Mn |
| Mar 31, 2024 | -16.56 Mn |
| Dec 31, 2023 | -24.34 Mn |
| Dec 31, 2023 | -24.34 Mn |
| Sep 30, 2023 | -90.85 Mn |
| Sep 30, 2023 | -90.85 Mn |
| Jun 30, 2023 | -80.52 Mn |
| Jun 30, 2023 | -80.52 Mn |